 |
|
|
| |
Sofosbuvir + Velpatasvir + Voxilaprevir in DAA Failure Patients
with Cirrhosis
Final Results of the French Compassionate Use Program
|
| |
| |
Reported by Jules Levin
EASL 2019 April 10-14 Vienna
C HEZODE1, D GUYADER2, E NGUYEN-KHAC3, D LARREY4, R TRUCHI5, V DI MARTINO6, Y CALMUS7, A MINELLO FRANZA8, N GIUILY GUIGUI9, S MOKHTARI10, K HARTIG-LAVIE11, L
COTTE11, D RIBARD12, MA VALANTIN7, L BONYHAY7, M ANTONINI13, JP BRONOWICKI14, JM COMBIS15, C PILETTE16, C ZAMORA10, D POINSOT11, JP ARPURT17, C RENOU18, M BOULIERE10,
V GRANDO19, F ROUDOT-THORAVAL1, V CANVA20
1 CRETEIL, 2 RENNES, 3 AMIENS, 4 MONTPELLIER, 5 NICE, 6 BESANÇON, 7 PARIS, 8 DIJON, 9 CLICHY, 10 MARSEILLE, 11 LYON, 12 NIMES, 13 ORANGE, 14 NANCY, 15 TOULOUSE, 16 LE
MANS, 17 AVIGNON, 18 HYERES, 19 BONDY, 20 LILLE, FRANCE
|
| |
|
|
|
|
|
